Skip to Main Content

Author Details

Daniel S Higginson
Memorial Sloan Kettering Cancer Center
2003
57
22
PMIDPaper TitleJournal TitlePublished Year
37748124Prophylactic Radiation Therapy Versus Standard of Care for Patients With High-Risk Asymptomatic Bone Metastases: A Multicenter, Randomized Phase II Clinical Trial.J Clin Oncol2024
36272727Long-Term Clinical Outcomes of Patients with Colorectal Cancer with Metastatic Epidural Spinal Cord Compression Treated with Hybrid Therapy (Surgery Followed by Stereotactic Body Radiation Therapy).World Neurosurg2023
37276242High Specificity of HPV Cell-Free DNA Tests in Persons With HIV for the Detection of HPV-Related Cancer.J Acquir Immune Defic Syndr2023
36477376The Impact of Targetable Mutations on Clinical Outcomes of Metastatic Epidural Spinal Cord Compression in Patients With Non-Small-Cell Lung Cancer Treated With Hybrid Therapy (Surgery Followed by Stereotactic Body Radiation Therapy).Neurosurgery2023
36449664Dynamic Mutational Landscape of Cerebrospinal Fluid Circulating Tumor DNA and Predictors of Survival after Proton Craniospinal Irradiation for Leptomeningeal Metastases.Clin Cancer Res2023
35334417Overview of health-related quality of life and toxicity of non-small cell lung cancer patients receiving curative-intent radiotherapy in a real-life setting (the REQUITE study).Lung Cancer2022
35385581Templated Insertions Are Associated Specifically with BRCA2 Deficiency and Overall Survival in Advanced Ovarian Cancer.Mol Cancer Res2022
36845624Early Detection of Leptomeningeal Metastases Among Patients Undergoing Spinal Stereotactic Radiosurgery.Adv Radiat Oncol2022
36195214The correlation between pre-treatment symptoms, acute and late toxicity and patient-reported health-related quality of life in non-small cell lung cancer patients: Results of the REQUITE study.Radiother Oncol2022
35287317Clinical Outcomes of Dose-Escalated Hypofractionated External Beam Radiation Therapy (5 Gy ÿ 5 Fractions) for Spine Metastasis.Adv Radiat Oncol2022
35092538Examining the prevalence of homologous recombination repair defects in ER+â¿¿breast cancers.Breast Cancer Res Treat2022
35023875Hybrid Therapy (Surgery and Radiosurgery) for the Treatment of Renal Cell Carcinoma Spinal Metastases.Neurosurgery2022
32970144Survival Trends After Surgery for Spinal Metastatic Tumors: 20-Year Cancer Center Experience.Neurosurgery2021
33877327Measuring nonhomologous end-joining, homologous recombination and alternative end-joining simultaneously at an endogenous locus in any transfectable human cell.Nucleic Acids Res2021
34708910Failure mode and effect analysis for linear accelerator-based paraspinal stereotactic body radiotherapy.J Appl Clin Med Phys2021
34585024Should Postoperative Radiation for Long Bone Metastases Cover Part or All of the Orthopedic Hardware? Results of a Large Retrospective Analysis.Adv Radiat Oncol2021
34696429Genomic Signatures in HPV-Associated Tumors.Viruses2021
33941615Disabling the Fanconi Anemia Pathway in Stem Cells Leads to Radioresistance and Genomic Instability.Cancer Res2021
33429428Precision Radiotherapy: Reduction in Radiation for Oropharyngeal Cancer in the 30 ROC Trial.J Natl Cancer Inst2021
32707555Hypofractionated spinal stereotactic body radiation therapy for high-grade epidural disease.J Neurosurg Spine2020
33102818Replacing 30 Gy in 10 fractions with stereotactic body radiation therapy for bone metastases: A large multi-site single institution experience 2016-2018.Clin Transl Radiat Oncol2020
32718762Stereotactic Radiosurgery and Stereotactic Body Radiotherapy in the Management of Oligometastatic Disease.Clin Oncol (R Coll Radiol)2020
30480549Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.J Clin Invest2019
31297376Adjacent level fracture incidence in single fraction high dose spinal radiosurgery.Ann Transl Med2019
31381960The Implications of Genetic Testing on Radiation Therapy Decisions: A Guide for Radiation Oncologists.Int J Radiat Oncol Biol Phys2019
31628294Long-term outcomes of high-dose single-fraction radiosurgery for chordomas of the spine and sacrum.J Neurosurg Spine2019
31485558Detection of Early Human Papillomavirus-Associated Cancers by Liquid Biopsy.JCO Precis Oncol2019
31338785Treatment of dedifferentiated chordoma: a retrospective study from a large volume cancer center.J Neurooncol2019
31591214Human papillomavirus 16 promotes microhomology-mediated end-joining.Proc Natl Acad Sci U S A2019
30633423Treatment modalities and outcomes of Fanconi anemia patients with head and neck squamous cell carcinoma: Series of 9 cases and review of the literature.Head Neck2019
29372858Myositis following spine radiosurgery for metastatic disease: a case series.J Neurosurg Spine2018
28041314Spinal stereotactic body radiotherapy following intralesional curettage with separation surgery for initial or salvage chordoma treatment.Neurosurg Focus2017
28299801Bi-allelic alterations in DNA repair genes underpin homologous recombination DNA repair defects in breast cancer.J Pathol2017
29021619Pan-cancer analysis of bi-allelic alterations in homologous recombination DNA repair genes.Nat Commun2017
28640703Integrating Evidence-Based Medicine for Treatment of Spinal Metastases Into a Decision Framework: Neurologic, Oncologic, Mechanicals Stability, and Systemic Disease.J Clin Oncol2017
28899042Stereotactic Radiosurgery: The Revolutionary Advance in the Treatment of Spine Metastases.Neurosurgery2017
28041329The impact of histology and delivered dose on local control of spinal metastases treated with stereotactic radiosurgery.Neurosurg Focus2017
27052795Biological Features of Human Papillomavirus-related Head and Neck Cancers Contributing to Improved Response.Clin Oncol (R Coll Radiol)2016
26589432Taselisib (GDC-0032), a Potent β-Sparing Small Molecule Inhibitor of PI3K, Radiosensitizes Head and Neck Squamous Carcinomas Containing Activating PIK3CA Alterations.Clin Cancer Res2016
27084629Exponential Increase in Relative Biological Effectiveness Along Distal Edge of a Proton Bragg Peak as Measured by Deoxyribonucleic Acid Double-Strand Breaks.Int J Radiat Oncol Biol Phys2016
23936342External beam radiotherapy for head and neck cancers is associated with increased variability in retinal vascular oxygenation.PLoS One2013
21935913Predicting the need for palliative thoracic radiation after first-line chemotherapy for advanced nonsmall cell lung carcinoma.Cancer2012
22857887The impact of local and regional disease extent on overall survival in patients with advanced stage IIIB/IV non-small cell lung carcinoma.Int J Radiat Oncol Biol Phys2012
22230037Challenges scoring radiation pneumonitis in patients irradiated for lung cancer.Lung Cancer2012
21194733Stereotactic body radiotherapy (SBRT): Technological innovation and application in gynecologic oncology.Gynecol Oncol2011
21813742Non-small cell lung cancer: prognostic importance of positive FDG PET findings in the mediastinum for patients with N0-N1 disease at pathologic analysis.Radiology2011
21134656Elective regional nodal irradiation in patients with early-stage breast cancer.Semin Radiat Oncol2011
20685582Current status of postoperative radiation for non-small-cell lung cancer.Semin Radiat Oncol2010
19286972Bilirubin and glutathione have complementary antioxidant and cytoprotective roles.Proc Natl Acad Sci U S A2009
17513821Pleural mesothelioma metastatic to tongue.J Clin Oncol2007
  • 1 - 50 of 57

Recommended Authors

Stanford University
Career Start Year 2014
Number of shared co-authors 3
Western University and London Regional Cancer Program
Career Start Year 2013
Number of shared co-authors 4
Princess Margaret Cancer Centre, University of Toronto
Career Start Year 2013
Number of shared co-authors 1
University Hospitals Seidman Cancer Centre, Cleveland Medical Centre
Career Start Year 2012
Number of shared co-authors 4
National Cancer Centre Singapore
Career Start Year 2011
Number of shared co-authors 11
Princess Margaret Cancer Centre
Career Start Year 2010
Number of shared co-authors 1
Johns Hopkins University School of Medicine
Career Start Year 2009
Number of shared co-authors 1
University of California San Diego Health
Career Start Year 2008
Number of shared co-authors 0
University of California los angeles
Career Start Year 2007
Number of shared co-authors 1
Princess Margaret Cancer Centre, University Health Network
Career Start Year 2002
Number of shared co-authors 4
Oregon Health and Sciences University
Career Start Year 2002
Number of shared co-authors 1
University Hospitals Bristol and Weston NHS Foundation Trust
Career Start Year 2001
Number of shared co-authors 1
University of Colorado School of Medicine
Career Start Year 2000
Number of shared co-authors 6
University of California Los Angeles
Career Start Year 2000
Number of shared co-authors 3
Case Western Reserve University
Career Start Year 2000
Number of shared co-authors 3
Center for Cancer Research, University of Tennessee Health Science Center
Career Start Year 1999
Number of shared co-authors 5
University of Alabama at Birmingham, O'Neal Comprehensive Cancer Center
Career Start Year 1999
Number of shared co-authors 0
Stanford University
Career Start Year 1999
Number of shared co-authors 4
University of California san francisco
Career Start Year 1998
Number of shared co-authors 2
University of Maryland School of Medicine
Career Start Year 1996
Number of shared co-authors 3
UT Southwestern Medical Center, Center for Human Nutrition
Career Start Year 1996
Number of shared co-authors 4
The University of Texas MD Anderson Cancer Center
Career Start Year 1995
Number of shared co-authors 4
Princess Margaret Cancer Centre, University Health Network
Career Start Year 1993
Number of shared co-authors 2
Institute of Pathology, Heidelberg University Hospital
Career Start Year 1991
Number of shared co-authors 0
Oregon Health & Science University
Career Start Year 1990
Number of shared co-authors 1
University of Toronto
Career Start Year 1989
Number of shared co-authors 9
Princess Margaret Cancer Centre, University Health Network, University of Toronto
Career Start Year 1988
Number of shared co-authors 13
Mayo Clinic
Career Start Year 1982
Number of shared co-authors 2
Massachusetts General Hospital
Career Start Year 1982
Number of shared co-authors 1
Princess Margaret Cancer Centre/University Health Network, University of Toronto
Career Start Year 1982
Number of shared co-authors 13

Collaborators

Memorial Sloan Kettering Cancer Center
Co-authored papers 15
Memorial Sloan Kettering Cancer Center
Co-authored papers 8
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Memorial Sloan Kettering Cancer Center
Co-authored papers 6
Memorial Sloan Kettering Cancer Center
Co-authored papers 5
Memorial Sloan Kettering Cancer Center
Co-authored papers 4
Kasturba Medical College, Manipal Academy of Higher Education (MAHE)
Co-authored papers 4
Memorial Sloan-Kettering Cancer Center
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
Co-authored papers 3
Memorial Sloan Kettering Cancer Center
Co-authored papers 3
University of Manchester
Co-authored papers 3
University of Manchester and The Christie NHS Foundation Trust
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Co-authored papers 2
Memorial Sloan Kettering Cancer Center
Co-authored papers 2
Maastro Clinic
Co-authored papers 2
University of Utah School of Medicine
Co-authored papers 2
German Cancer Research Center (DKFZ)
Co-authored papers 2
University of Western Ontario
Co-authored papers 1
Co-authored papers 1
Co-authored papers 1
Cleveland Clinic.
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Memorial Sloan Kettering Cancer Center
Co-authored papers 1
Yale University School of Medicine
Co-authored papers 1